GlassScriptPhysician profile
Bradley Nelson
NPI 1093027799
$13,252.35
in general payments reported to CMS, 2019-2025
37 companies · $3,334 in 2025
The $3,334 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $801 · 2021: $588 · 2022: $1,509 · 2023: $2,584 · 2024: $3,581 · 2025: $3,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,418 · Travel and Lodging: $2,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,418.45 |
| Travel and Lodging | $2,080.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,609.57 | 2019-2025 | Avvigo Guidance System, Crossboss, General - Balloon Catheters |
| Bayer Healthcare Pharmaceuticals INC. | $1,583.81 | 2024 | |
| Philips North America LLC | $1,161.05 | 2022-2023 | |
| Shockwave Medical, INC | $1,101.92 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $936.20 | 2019-2025 | Cardiomems, Dragonfly Opstar, Gallant |
| Medtronic, INC. | $647.68 | 2021-2025 | Symplicity G3, Micra, Azure Xt Dr Mri Surescan |
| Abiomed | $614.61 | 2021-2025 | Impella |
| Biosense Webster, INC. | $432.49 | 2024-2025 | Carto 3, Na, Soundstar |
| Teleflex LLC | $354.55 | 2024-2025 | Supercross, Turnpike |
| Medtronic Vascular, INC. | $319.90 | 2019-2020 | |
| Cardiovascular Systems INC. | $284.07 | 2019 | |
| Edwards Lifesciences Corporation | $253.80 | 2022-2025 | Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $252.78 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $190.93 | 2019-2024 | Camzyos |
| Penumbra, INC. | $162.73 | 2023 | Indigo System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $137.84 | 2025 | Attruby |
| Janssen Pharmaceuticals, INC | $125.30 | 2019-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $114.01 | 2025 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $100.04 | 2019-2021 | |
| Amgen INC. | $98.77 | 2019-2022 | |
| Cvrx, INC. | $96.66 | 2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.58 | 2021-2024 | Jardiance |
| Asahi Intecc USA, INC. | $84.12 | 2020 | |
| Siemens Medical Solutions USA, INC. | $74.16 | 2023 | Acuson Sc2000 Diagnostic Ultrasound System |
| Merit Medical Systems INC | $62.81 | 2025 | Embocath Plus Microcatheter |
| Pfizer INC. | $61.52 | 2019-2020 | |
| Reflow Medical INC | $53.85 | 2024 | |
| Sanofi-Aventis U.S. LLC | $42.79 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $37.09 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.56 | 2023 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $29.26 | 2019 | |
| Atricure, INC. | $28.44 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $21.41 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.29 | 2020 | |
| Akcea Therapeutics, INC. | $18.76 | 2020 | |
| Zoll Circulation INC | $8.00 | 2024 | Downstream Cartridge, Therox Ds2 Console, Catheter |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.